Nuclear Medicine (Radio Isotopes) Market

Global Nuclear Medicine (Radio Isotopes) Market – Analysis and Forecast (2025-2030)  Industry Insight by Type (Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals and PET Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters and Beta Emitters), and Brachytherapy Isotopes (Iodine-125, Palladium-103, Cesium-131, Iridium-192, and Other Brachytherapy Isotopes), by Application (SPECT Applications (Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, and Others), PET Applications (Oncology, Cardiology, Neurology, and Others), and Therapeutic Applications (Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, and Other Indications), by End User (Hospitals and Diagnostic Centers, and Research Institutes), and Geography (U.S., Canada, Germany, U.K., France, China, Japan, India, and Rest of the World)